行情

ATRC

ATRC

AtriCure
NASDAQ

实时行情|Nasdaq Last Sale

39.82
-0.59
-1.46%
交易中 12:28 08/14 EDT
开盘
40.17
昨收
40.41
最高
40.48
最低
39.51
成交量
7.09万
成交额
--
52周最高
51.76
52周最低
22.57
市值
17.89亿
市盈率(TTM)
-30.8467
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ATRC价格均价为55.63,最高价位63.00,最低价为50.00。

EPS

ATRC 新闻

更多
AtriCure Announces Angie Wirick as Chief Financial Officer
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, announced today that Andy Wade is stepping down from the position of Chief Financial Officer (CFO) for personal reasons
Business Wire · 08/06 20:00
AtriCure Inc. (ATRC): Were Hedge Funds Right About Buying This Stock?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional invest
Insider Monkey · 08/03 12:55
AtriCure to Participate at Upcoming Investor Conferences
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in several upcoming investor conferences.
Business Wire · 07/29 12:00
AtriCure Inc (ATRC) Q2 2020 Earnings Call Transcript
Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond AtriCure's control, including risks and uncertainties described from time-to-time in AtriCure's SEC filings. AtriCure's results may differ materially from tho
Motley Fool · 07/29 09:01
More on AtriCure Q2 earnings
Seeking Alpha · 07/29 04:00
Recap: AtriCure Q2 Earnings
Shares of AtriCure (NASDAQ:ATRC) were flat in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share fell 123.53% over the past year to ($0.38), which beat the estimate of ($0.61).Revenue of $40,824,000 decreased by 30.
Benzinga · 07/28 20:22
AtriCure EPS beats by $0.16, beats on revenue
Seeking Alpha · 07/28 20:07
AtriCure Reports Second Quarter 2020 Financial Results
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced second quarter 2020 financial results.
Business Wire · 07/28 20:01

所属板块

医疗设备、用品及经销
-1.02%
医疗设备和用品
-1.13%

热门股票

代码
价格
涨跌幅

ATRC 简况

AtriCure, Inc.是一家提供心房颤动(Afib)解决方案的医疗设备公司。该公司开发、制造和销售主要用于心脏组织的手术消融设备及用于左心耳预防的系统。该公司拥有各种用于心脏组织消融的产品系列,包括其用于治疗经历某些开放伴随手术患者的持续和长期持续形式的Afib的Isolator Synergy Ablation System。其Isolator Synergy System包括其Isolator Synergy夹钳、射频(RF)发生器和相关开关盒,以及为持续和长期持续性Afib伴随提供疗法。它有两个主要用于心脏组织消融的产品,包括Radio Frequency Ablation Devices和cryoICE Cryoablation System,以及1个用于左心耳预防的产品。
展开

微牛提供AtriCure Inc.(NASDAQ-ATRC)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ATRC股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易ATRC股票基本功能。